Core Viewpoint - The FDA has issued stern warning letters to major retailers including Walmart and Target for failing to properly recall baby formula linked to a botulism outbreak, with Kroger and Albertsons also criticized for continuing to sell the affected product [2][3][4]. Group 1: FDA Warnings and Retailer Actions - The FDA has confirmed that the baby formula in question is linked to at least 51 suspected or confirmed cases of infant botulism across 19 states as of December 10 [2][4]. - Target has been criticized for inadequate response measures, continuing to promote the affected formula even after the recall was initiated [2][3]. - The FDA emphasized that all four retailers, including Walmart, Target, Kroger, and Albertsons, failed to provide evidence of corrective actions taken after multiple communications [2][3]. Group 2: Impact of the Outbreak - The CDC has described the severity of the outbreak as "unprecedented," marking the first large-scale infant botulism outbreak in the U.S. [3][8]. - Symptoms of infant botulism can include difficulty eating, loss of head control, swallowing and breathing difficulties, and a weak cry, with a potential incubation period of several weeks [9][10]. Group 3: Retailer Responses - Walmart stated it would formally respond to the FDA's warning and has taken steps to limit the sale of the affected product after receiving the recall notice [10]. - As of now, Target, Kroger, and Albertsons have not provided comments regarding the situation [10].

Core Viewpoint - Recent reports indicate a rise in infant botulism cases in the U.S., potentially linked to contaminated infant formula produced by ByHeart, prompting a recall of two batches of the product [1][2]. Group 1: Incident Overview - The CDC reported 13 cases of infant botulism across 10 states, all involving ByHeart's "nutritionally complete infant formula" [1]. - Affected infants, aged between 16 days and 157 days, have been hospitalized and treated with BabyBIG, with no fatalities reported [1]. - The outbreak is under investigation by the CDC, FDA, and state health departments, with ongoing testing of remaining formula samples [1]. Group 2: Company and Market Impact - ByHeart's "nutritionally complete infant formula" holds less than 1% market share in the U.S. infant formula market, indicating that this incident is unlikely to affect the overall supply of infant formula in the country [2]. - Early symptoms of infant botulism include constipation, decreased head control, and difficulty swallowing, with severe cases potentially leading to respiratory failure [2].